A potent phosphodiester Keap1-Nrf2 protein-protein interaction inhibitor as the efficient treatment of Alzheimer's disease
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A potent phosphodiester Keap1-Nrf2 protein-protein interaction inhibitor as the efficient treatment of Alzheimer's disease
Authors
Keywords
-
Journal
Redox Biology
Volume -, Issue -, Pages 102793
Publisher
Elsevier BV
Online
2023-06-25
DOI
10.1016/j.redox.2023.102793
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Omaveloxolone: First Approval
- (2023) Arnold Lee DRUGS
- Crystallography-Guided Optimizations of the Keap1–Nrf2 Inhibitors on the Solvent Exposed Region: From Symmetric to Asymmetric Naphthalenesulfonamides
- (2022) Guodong Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Efficacy of Omaveloxolone in Friedreich's Ataxia: Delayed‐Start Analysis of the MOXIe Extension
- (2022) David R. Lynch et al. MOVEMENT DISORDERS
- Mitochondrial Dysfunction and Oxidative Stress in Alzheimer’s Disease
- (2021) Afzal Misrani et al. Frontiers in Aging Neuroscience
- Deconstructing Noncovalent Kelch-like ECH-Associated Protein 1 (Keap1) Inhibitors into Fragments to Reconstruct New Potent Compounds
- (2021) Jakob S. Pallesen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Molecular basis for the disruption of Keap1–Nrf2 interaction via Hinge & Latch mechanism
- (2021) Yuta Horie et al. Communications Biology
- Structure-based molecular hybridization design of Keap1-Nrf2 inhibitors as novel protective agents of acute lung injury
- (2021) Le Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Ligand-based substituent-anchoring design of selective receptor-interacting protein kinase 1 necroptosis inhibitors for ulcerative colitis therapy
- (2021) Jing Zhu et al. Acta Pharmaceutica Sinica B
- Oxidative stress in the pathogenesis of Alzheimer’s disease and cerebrovascular disease with therapeutic implications.
- (2020) Anamaria Jurcau et al. CNS & Neurological Disorders-Drug Targets
- Nrf2 Suppresses Oxidative Stress and Inflammation in App Knock-In Alzheimer’s Disease Model Mice
- (2020) Akira Uruno et al. MOLECULAR AND CELLULAR BIOLOGY
- Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
- (2020) Helmut Sies et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Nrf2 Ablation Promotes Alzheimer’s Disease-Like Pathology in APP/PS1 Transgenic Mice: The Role of Neuroinflammation and Oxidative Stress
- (2020) Peng Ren et al. Oxidative Medicine and Cellular Longevity
- Structural insights into the multiple binding modes of Dimethyl Fumarate (DMF) and its analogs to the Kelch domain of Keap1
- (2020) Sruthi Unni et al. FEBS Journal
- Safety and Efficacy of Omaveloxolone in Friedreich's Ataxia ( MOXIe Study)
- (2020) David R. Lynch et al. ANNALS OF NEUROLOGY
- Direct inhibition of Keap1-Nrf2 Protein-Protein interaction as a potential therapeutic strategy for Alzheimer's disease
- (2020) Yi Sun et al. BIOORGANIC CHEMISTRY
- Recent progress in Keap1-Nrf2 protein-protein interaction inhibitors
- (2020) Yi Mou et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis of New Tyrosol‐Based Phosphodiester Derivatives: Effect on Amyloid β Aggregation and Metal Chelation Ability
- (2020) Valeria Romanucci et al. ChemMedChem
- Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
- (2019) Antonio Cuadrado et al. NATURE REVIEWS DRUG DISCOVERY
- Neuroprotective Effect of Swertiamain on Cerebral Ischemia/Reperfusion Injury by Inducing the Nrf2 Protective Pathway
- (2019) Hui Wang et al. ACS Chemical Neuroscience
- NRF2/ARE pathway negatively regulates BACE1 expression and ameliorates cognitive deficits in mouse Alzheimer’s models
- (2019) Gahee Bahn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fragment-growing guided design of Keap1-Nrf2 protein-protein interaction inhibitors for targeting myocarditis
- (2018) Ning Meng et al. FREE RADICAL BIOLOGY AND MEDICINE
- Oxidative Stress, Amyloid-β Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer’s Disease
- (2018) D. Allan Butterfield et al. JOURNAL OF ALZHEIMERS DISEASE
- Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
- (2018) C. Cheignon et al. Redox Biology
- BACE1 as a Potential Biomarker for Alzheimer's Disease
- (2018) Boris Decourt et al. JOURNAL OF ALZHEIMERS DISEASE
- Distribution of Pathology in Frontal Variant Alzheimer's Disease
- (2018) Richard Blennerhassett et al. JOURNAL OF ALZHEIMERS DISEASE
- Activated charcoal significantly improved the reliability of methods for quantitative analysis of endogenous substances in biological specimens: Glutathione and cysteine as cases
- (2018) Boyu Shen et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Aberration of Nrf2‑Bach1 pathway in colorectal carcinoma; role in carcinogenesis and tumor progression
- (2018) Heba E.M. El-Deek et al. Annals of Diagnostic Pathology
- Small molecules inhibiting Keap1–Nrf2 protein–protein interactions: a novel approach to activate Nrf2 function
- (2017) Chunlin Zhuang et al. MedChemComm
- Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer’s disease
- (2017) Fiona Kerr et al. PLoS Genetics
- Distinct inflammatory phenotypes of microglia and monocyte-derived macrophages in Alzheimer's disease models: effects of aging and amyloid pathology
- (2016) Elodie Martin et al. AGING CELL
- Redox-based therapeutics in neurodegenerative disease
- (2016) G J McBean et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Cellular Phase of Alzheimer’s Disease
- (2016) Bart De Strooper et al. CELL
- The amyloid hypothesis of Alzheimer's disease at 25 years
- (2016) Dennis J Selkoe et al. EMBO Molecular Medicine
- Discovery and Development of Kelch-like ECH-Associated Protein 1. Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein–Protein Interaction Inhibitors: Achievements, Challenges, and Future Directions
- (2016) Zheng-Yu Jiang et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update
- (2016) Meng-Chen Lu et al. MEDICINAL RESEARCH REVIEWS
- Small molecules, big targets: drug discovery faces the protein–protein interaction challenge
- (2016) Duncan E. Scott et al. NATURE REVIEWS DRUG DISCOVERY
- BACE1 in the retina: a sensitive biomarker for monitoring early pathological changes in Alzheimer′s disease
- (2016) Hui Wang et al. Neural Regeneration Research
- Nrf2—a therapeutic target for the treatment of neurodegenerative diseases
- (2015) Delinda A. Johnson et al. FREE RADICAL BIOLOGY AND MEDICINE
- Updated Research and Applications of Small Molecule Inhibitors of Keap1-Nrf2 Protein-Protein Interaction: a Review
- (2014) Chunlin Zhuang et al. CURRENT MEDICINAL CHEMISTRY
- Rapid Identification of Keap1–Nrf2 Small-Molecule Inhibitors through Structure-Based Virtual Screening and Hit-Based Substructure Search
- (2014) Chunlin Zhuang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52
- (2014) Chulman Jo et al. Nature Communications
- Oxidative stress and mitochondrial dysfunction in Alzheimer's disease
- (2013) Xinglong Wang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Keap Calm, and Carry on Covalently
- (2013) Anthony J. Wilson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
- (2013) Dick de Zeeuw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Attenuation ofβ-Amyloid-Induced Oxidative Cell Death by Sulforaphane via Activation of NF-E2-Related Factor 2
- (2013) Chan Lee et al. Oxidative Medicine and Cellular Longevity
- Small Molecule Modulators of Keap1-Nrf2-ARE Pathway as Potential Preventive and Therapeutic Agents
- (2012) Sadagopan Magesh et al. MEDICINAL RESEARCH REVIEWS
- Remarkable Potential of the α-Aminophosphonate/Phosphinate Structural Motif in Medicinal Chemistry
- (2011) Artur Mucha et al. JOURNAL OF MEDICINAL CHEMISTRY
- Integration, scaling, space-group assignment and post-refinement
- (2010) Wolfgang Kabsch ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- XDS
- (2010) Wolfgang Kabsch ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Oxidative stress in Alzheimer disease
- (2010) Alejandro Gella et al. Cell Adhesion & Migration
- Triterpenoid CDDO-methylamide improves memory and decreases amyloid plaques in a transgenic mouse model of Alzheimer’s disease
- (2009) Magali Dumont et al. JOURNAL OF NEUROCHEMISTRY
- Bicyclol: A Novel Drug for Treating Chronic Viral Hepatitis B and C
- (2009) Geng Liu Medicinal Chemistry
- Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer's disease
- (2009) K. Kanninen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prodrugs of Phosphates and Phosphonates
- (2008) Scott J. Hecker et al. JOURNAL OF MEDICINAL CHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started